Login / Signup

Tenofovir does not induce renal dysfunction compared to entecavir in post-liver-transplant hepatitis B virus patients.

Sang-Jin KimJinsoo RhuSeo Hee LeeJong Man KimGyu Seong ChoiKyunga KimJae-Won Joh
Published in: Annals of surgical treatment and research (2020)
Tenofovir disoproxil fumarate does not induce renal dysfunction in liver-transplanted patients with HBV more than does entecavir.
Keyphrases
  • hepatitis b virus
  • end stage renal disease
  • liver failure
  • ejection fraction
  • oxidative stress
  • chronic kidney disease
  • peritoneal dialysis
  • antiretroviral therapy
  • patient reported outcomes